公开(公告)号：US20160026770A1

公开(公告)日：2016-01-28

申请号：US14877083

申请日：2015-10-07

Applicant: AJINOMOTO CO., INC.

Inventor： Takayuki TANAKA ,  Kenji NAGAO ,  Akira IMAIZUMI ,  Minoru YAMAKADO

IPC: G06F19/00

CPC classification number: G01N33/6812 ,  G16H50/30

Abstract: A method of evaluating lifestyle-related disease indicator includes (i) an obtaining step of obtaining amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated and (ii) an evaluating step of evaluating a state of an indicator of lifestyle-related disease for the subject using the concentration values of the amino acids of Gly and Tyr included in the amino acid concentration data of the subject obtained at the obtaining step.

Abstract translation: 评价生活方式相关疾病指标的方法包括：（i）获得从待评价对象收集的血液中获得氨基酸浓度值的氨基酸浓度数据的获取步骤，以及评价步骤， 使用包含在获得步骤中获得的受试者的氨基酸浓度数据中的Gly和Tyr的氨基酸的浓度值的对象的生活方式相关疾病的指标。

公开(公告)号：US20210205252A1

公开(公告)日：2021-07-08

申请号：US17301076

申请日：2021-03-24

Applicant: AJINOMOTO CO., INC.

Inventor： Susan GINGRICH ,  Robert REED ,  Kenji NAGAO ,  Natsumi NISHIKATA

IPC: A61K31/198 ,  A23L33/00 ,  A23L33/19 ,  A23L33/155 ,  A23L33/29 ,  A61P25/08 ,  A61K9/00 ,  A23L33/115 ,  A61K8/44

Abstract: Described herein are nutritional compositions, such as ketogenic compositions, leucine-enriched amino acid mixtures, etc., useful, for example, for dietary management of intractable epilepsy. In some embodiments, the disclosure relates to methods of inhibiting epileptic seizures in a subject comprising administering to the subject a leucine-enriched amino acid mixture.

公开(公告)号：US20250093361A1

公开(公告)日：2025-03-20

申请号：US18897474

申请日：2024-09-26

Applicant: Ajinomoto Co., Inc.

Inventor： Takayuki TANAKA ,  Kenji NAGAO ,  Akira IMAIZUMI ,  Minoru YAMAKADO

IPC: G01N33/68 ,  G16H50/30

Abstract: A method of evaluating lifestyle-related disease indicator includes (i) an obtaining step of obtaining amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated and (ii) an evaluating step of evaluating a state of an indicator of lifestyle-related disease for the subject using the concentration values of the amino acids of Gly and Tyr included in the amino acid concentration data of the subject obtained at the obtaining step.

公开(公告)号：US20170206335A1

公开(公告)日：2017-07-20

申请号：US15479786

申请日：2017-04-05

Applicant: AJINOMOTO CO., INC.

Inventor： Kenji NAGAO ,  Akira IMAIZUMI ,  Minoru YAMAKADO

IPC: G06F19/00 ,  G01N33/68

CPC classification number: G16H50/30 ,  G01N33/6806 ,  G01N2800/22 ,  G01N2800/2871 ,  G01N2800/326 ,  G01N2800/50

Abstract: An evaluating method includes an evaluating step of evaluating a future risk of lifestyle-related disease for a subject to be evaluated using a concentration value of an amino acid included in amino acid concentration data on the concentration value of the amino acid in blood collected from the subject.